Drug intelligence / Profile preview

SourceCF Multivitamin

Development stage: Unknown
Lead developer: Source Commercial Finance
Administration: Oral

Overview

SourceCF Multivitamin is a specialized multivitamin and mineral dietary supplement formulated for patients with cystic fibrosis and related conditions associated with malabsorption of fat-soluble vitamins, providing enhanced levels of fat-soluble and water-soluble vitamins to prevent or correct deficiencies. It is used as a daily oral supplement, often in place of other CF-focused vitamin formulations, to support nutritional status in individuals with pancreatic insufficiency and other causes of malabsorption. As a multinutrient supplement, its effects are nonspecific and supportive rather than mediated through a single molecular target, and it is not developed or regulated as a conventional pharmaceutical drug.

Brand names: SourceCF MultivitaminSource CF

Beyond the preview

Go deeper on SourceCF Multivitamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SourceCF Multivitamin.

Explore the full profile